financetom
Business
financetom
/
Business
/
Rubrik Shares Dip After Q2 Results: Earnings Beat, Revenues Beat, Guidance Above Estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rubrik Shares Dip After Q2 Results: Earnings Beat, Revenues Beat, Guidance Above Estimates
Sep 10, 2024 8:17 AM

Rubrik Inc. ( RBRK ) reported its second-quarter financial results after Monday's closing bell. Here's a look at the details from the report. 

The Details: Rubrik ( RBRK ) reported quarterly losses of 40 cents per share which beat the analyst consensus estimate of losses of 49 cents. Quarterly sales came in at $204.951 million, which beat the analyst consensus estimate of $196.209 million by 4.46%.

Subscription ARR was up 40% year-over-year, growing to $919.1 million.

Subscription revenue was $191.3 million, a 50% increase, compared to $127.5 million in the second quarter of fiscal 2024.

GAAP gross margin was 73.1%, compared to 76.6% in the second quarter.

Rubrik ( RBRK ) reported 1,969 customers with $100K or more in Subscription ARR, up 35% year-over-year.

“The long list of recent successful cyber attacks and IT outages is driving organizations to increasingly recognize the need for a robust cyber resilience plan to ensure business continuity in the face of cyber disruptions. Our Subscription ARR up 40% year-over-year in the second quarter to $919 million showcases the value we provide to enterprises in delivering complete cyber resilience, which combines cyber recovery and data security posture management,” said Bipul Sinha, Rubrik’s CEO.

Read Next: What’s Going On With GameStop Stock Ahead Of Earnings?

Outlook: Rubrik ( RBRK ) sees third-quarter losses of between 41 cents and 39 cents per share, versus the estimate of losses of 43 cents, and quarterly revenue in a range of $216.5 million to $218.5 million, versus the $215.15 million estimate. The company expects fiscal year losses of between $2.12 and $2.06 per share, versus the estimate of losses of $2.28 per share, and full-year revenue in a range of $830 million to $838 million, versus the $818.45 million estimate.

The company will host a conference call at 5 p.m. ET to discuss the results. 

RBRK Price Action: According to Benzinga Pro, Rubrik ( RBRK ) shares are down 4.05% after-hours at $30.76 at the time of publication Monday.

Read Also:

Dell Technologies To Be Included In S&P 500: What’s Going On With The Stock?

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved